PRECLINICAL ALZHEIMER'S DISEASE
Clinical trials for PRECLINICAL ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new PRECLINICAL ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for PRECLINICAL ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine combo aims to slow Alzheimer's by targeting tau tangles
Disease control Not yet recruitingThis study tests a vaccine called AADvac1, which targets tau tangles in the brain, a hallmark of Alzheimer's. It will be given alone or with another drug (donanemab) to 450 adults aged 50-80 with very early Alzheimer's. The goal is to see if this approach can reduce tau buildup a…
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope: Alzheimer's trial targets tau tangles to slow memory loss
Disease control Not yet recruitingThis study tests whether drugs that target tau protein, alone or with donanemab, can reduce tau buildup and slow memory decline in people aged 50-80 with early Alzheimer's. Participants will receive treatment for 30 months and undergo brain scans and cognitive tests. The goal is …
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC